MRX DEADLINE: Rosen Warns Marex Group plc Investors to Act Before December 8, 2025

The Rosen Law Firm — a global investor‑rights law firm — is urging anyone who bought securities of Marex Group plc (NASDAQ: MRX) between May 16, 2024 and August 5, 2025 (both dates inclusive) to secure legal counsel before the upcoming lead‑plaintiff deadline on December 8, 2025. If you purchased Marex securities during that “Class Period,” you might be eligible for compensation through a contingency‑fee arrangement — meaning you pay nothing upfront. To participate in the class action, investors can submit a claim form via the Rosen website, call their toll‑free number, or email their case team. If you wish to be named lead plaintiff (i.e. represent the class), your motion must be filed by December 8. Why is Rosen pushing this now? According to the complaint cited in the filing, Marex allegedly sold over‑the‑counter instruments to itself, and reported inconsistent financials across subsidiaries and related parties. These practices — combined with alleged misleading statements about its business prospects — were reportedly hidden from investors. When the true state of finances came to light, shareholders allegedly incurred losses. Rosen advises that when choosing counsel, investors should prioritize firms with experience and a strong track record — not just those that send out mass mailings. Rosen itself has previously secured hundreds of millions in settlements for investors, including a record‑setting class‑action result against a major Chinese company. #Marex #MRX #ClassAction #InvestorAlert #SlimScan #GrowthStocks #CANSLIM